0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 39535 results.
Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are...
Catalog:
MRRPB5
February 2023
Price: USD 2,900.00
The global Virtual Colonoscopy Software market was valued at US$ 2211.4 million in 2023 and is anticipated to reach US$ 3004.7 million by 2030,...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Colitis - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colitis -...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
5-Hydroxytryptamine Receptor 7 (5 HT7 or 5 HTX or Serotonin Receptor 7 or HTR7) Drugs in Development by Therapy Areas and Indications, Stages, MoA,...
Catalog:
Global Markets Direct
May 2022
Price: USD 3,500.00
Highlights The global Beclomethasone market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
5-Hydroxytryptamine Receptor 7 - Drugs In Development, 2021 Summary According to the recently published report '5-Hydroxytryptamine Receptor 7...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Adalimumab is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
The global Stelara market size is expected to reach $ 5306.9 million by 2029, rising at a market growth of -3.0% CAGR during the forecast period (...
Catalog:
GIR
August 2023
Price: USD 4,480.00
The global Stelara market size is projected to grow from US$ 6251 million in 2022 to US$ 4953.9 million in 2029; it is expected to grow at a CAGR of...
Catalog:
LPI
July 2023
Price: USD 3,660.00
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global Humira...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Highlights The global Virtual Colonoscopy Software market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Human microbiome has co-evolved with humans for centuries, which includes bacteria, viruses, fungi, Achaeans etc. The human microbiome is now one of...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
PEGylating has been widely used as a post-production modification methodology for improving biomedical efficacy and physicochemical properties of...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global PEGylated Proteins market size was valued at US$ 3687 million in 2023. With growing demand in downstream market, the PEGylated Proteins is...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Adalimumab (Humira) and Biosimilar market size is projected to grow from US$ 21930 million in 2022 to US$ 14950 million in 2029; it is...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Filter By Report Date
Filter By Industry
Filter By Country
- Global (39158) Apply Global filter
- BRIC (2) Apply BRIC filter
- Asia (1) Apply Asia filter
- Caribbean (1) Apply Caribbean filter
- Emerging Markets (1) Apply Emerging Markets filter
- G8 (1) Apply G8 filter
- Korea (1) Apply Korea filter
- Latin America (1) Apply Latin America filter
- Oceania (1) Apply Oceania filter
